Article
The de novo autism spectrum disorder RELN R2290C mutation reduces Reelin secretion and increases protein disulfide isomerase expression.
Journal of neurochemistry - 1 Jul 2017
Lammert Dawn B, Middleton Frank A, Pan Jen, Olson Eric C, Howell Brian W
Abstract excerpt
Despite the recent identification of over 40 missense heterozygous Reelin gene (RELN) mutations in autism spectrum disorder (ASD), none of these has been functionally characterized. Reelin is an integral signaling ligand for proper brain development and post-natal synapse function - properties likely disrupted in ASD patients. We find that the R2290C mutation, which arose de novo in an affected ASD proband, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
